Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | Fidelity US Value Research Enhanced |
| Investment focus | Equity, United States, Value |
| Fund size | EUR 3 m |
| Total expense ratio | 0.20% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Investment approach | Actively managed |
| Sustainability | Yes |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 11.32% |
| Inception/ Listing Date | 4 December 2024 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Ireland |
| Fund Provider | Fidelity ETF |
| Fund Structure | other |
| UCITS compliance | Yes |
| Administrator | Brown Brothers Harriman Fund Administration Services (Ireland) Limited |
| Investment Advisor | Geode Capital Management, LLC |
| Custodian Bank | Brown Brothers Harriman Trustee Services (Ireland) Limited |
| Revision Company | Deloitte LLP |
| Fiscal Year End | 31 January |
| Swiss representative | BNP Paribas, Paris, succursale de Zurich |
| Swiss paying agent | BNP Paribas, Paris, succursale de Zurich |
| Germany | Unknown |
| Switzerland | No ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Italy | 26.0% |
| Indextype | - |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | No |
| Securities lending counterparty |
| NVIDIA Corp. | 6.98% |
| Apple | 6.20% |
| Alphabet, Inc. A | 5.10% |
| Microsoft | 4.55% |
| Broadcom Inc. | 2.51% |
| Eli Lilly & Co. | 1.68% |
| Visa, Inc. | 1.49% |
| APA | 1.30% |
| Caterpillar Inc /US | 1.29% |
| Procter & Gamble Co. | 1.23% |
| United States | 91.71% |
| Bermuda | 2.83% |
| United Kingdom | 1.40% |
| Other | 4.06% |
| Technology | 33.66% |
| Financials | 10.64% |
| Consumer Discretionary | 9.95% |
| Health Care | 9.90% |
| Other | 35.85% |
| Broker | Rating | Execution fee | Account fee | |
|---|---|---|---|---|
| 0.00 € | 0.00 € | View offer** | |
| 0.00 € | 0.00 € | View offer* | |
| 0.00 € | 0.00 € | View offer* | |
| 0.00 € | 0.00 € | View offer* | |
| 0.00 € | 0.00 € | View offer* |
| Broker | Rating | Order fee | ETF savings plans | |
|---|---|---|---|---|
| 0.99 € | 3199 | View offer** | |
| 0.00 € | 2611 | View offer* | |
| 0.00 € | 1868 | View offer* | |
| 1.00 € | 2629 | View offer* | |
| 0.00 € | 2276 | View offer* |
| YTD | +9.66% |
| 1 month | +3.57% |
| 3 months | +7.63% |
| 6 months | +8.98% |
| 1 year | +26.70% |
| 3 years | - |
| 5 years | - |
| Since inception (MAX) | +10.36% |
| 2025 | +3.25% |
| 2024 | - |
| 2023 | - |
| 2022 | - |
| Volatility 1 year | 11.32% |
| Volatility 3 years | - |
| Volatility 5 years | - |
| Return per risk 1 year | 2.36 |
| Return per risk 3 years | - |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | -5.09% |
| Maximum drawdown 3 years | - |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | -23.33% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| Borsa Italiana | EUR | FUSV | - - | - - | - |
| gettex | EUR | FUSV | - - | - - | - |
| London Stock Exchange | USD | FUSV | FUSV LN FUSVUSIV | FUSV.L FUSVUSDINAV=SOLA | Société Générale |
| London Stock Exchange | GBP | FUS1 | |||
| SIX Swiss Exchange | USD | FUSV | |||
| XETRA | EUR | FUSV |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| iShares Edge MSCI USA Value Factor UCITS ETF | 4,285 | 0.20% p.a. | Accumulating | Full replication |
| Ossiam Shiller Barclays CAPE® US Sector Value TR UCITS ETF 1C (USD) | 1,630 | 0.65% p.a. | Accumulating | Swap-based |
| Invesco RAFI US Fundamental Value UCITS ETF Dist | 719 | 0.39% p.a. | Distributing | Full replication |
| Ossiam Shiller Barclays CAPE® US Sector Value TR UCITS ETF 1C (EUR) | 637 | 0.65% p.a. | Accumulating | Swap-based |
| UBS MSCI USA Value UCITS ETF USD dis | 486 | 0.20% p.a. | Distributing | Full replication |